Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-22-012780
Filing Date
2022-03-30
Accepted
2022-03-30 16:00:27
Documents
2
Period of Report
2021-11-08

Document Format Files

Seq Description Document Type Size
1 FORM 3/A SUBMISSION doc3a.html 3/A  
1 FORM 3/A SUBMISSION doc3a.xml 3/A 1729
2 EX-24 DOCUMENT attachment1.htm EX-24 3446
  Complete submission text file 0000899243-22-012780.txt   6496
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Issuer) CIK: 0001492674 (see all company filings)

EIN.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 101 HARTWELL AVE. LEXINGTON MA 02421
Business Address
Giffin Brett A. (Reporting) CIK: 0001892921 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-36571 | Film No.: 22786333